Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating Ov329 Does Not Accumulate in Animal Eyes in Contrast With Vigabatrin
ovid therapeutics展示了一項預臨床研究結果,表明Ov329與維加巴林相比,不會在動物眼中積累
Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating Ov329 Does Not Accumulate in Animal Eyes in Contrast With Vigabatrin
ovid therapeutics展示了一項預臨床研究結果,表明Ov329與維加巴林相比,不會在動物眼中積累
譯文內容由第三人軟體翻譯。